The daily business briefing: March 7, 2018
The departure of Trump's top economic adviser weighs down stocks, Amazon's Jeff Bezos tops Forbes' list of billionaires, and more

- 1. Trump's top economic adviser resigns, dragging down stocks
- 2. Jeff Bezos tops Forbes billionaire list as Amazon fortune soars
- 3. Investors drop deal to buy Weinstein Co.
- 4. FDA says 23andMe can report on breast cancer risk
- 5. Oregon man sues Walmart, Dick's Sporting Goods over raising gun-sale age

1. Trump's top economic adviser resigns, dragging down stocks
President Trump's top economic adviser, Gary Cohn, is resigning, White House officials said Tuesday, after days of controversy over Trump's unexpected announcement that he would impose stiff tariffs on steel and aluminum imports. Cohn and other free-trade advocates, including leading Republican lawmakers, have argued against the tariffs, which have prompted threats of retaliatory import taxes by European officials. Global stocks and the dollar dropped on Wednesday as the departure of Cohn, one of the strongest voices for free trade in the Trump administration, fueled fears that Trump would trigger a trade war by pushing ahead with protectionist tariffs. U.S. stock futures fell sharply, pointing to a drop for the three major U.S. indexes at the opening bell.
2. Jeff Bezos tops Forbes billionaire list as Amazon fortune soars
Amazon CEO Jeff Bezos has surged past Microsoft founder and philanthropist Bill Gates to become the world's wealthiest person, according to the Forbes billionaires list, released Tuesday. Bezos' fortune was lifted by Amazon's stock gains to reach $112 billion, landing him at the top of the list for the first time. His fortune made the biggest one-year leap ever, climbing from $39.2 billion in 2017. Gates was in second place with a fortune of $90 billion, up from $86 billion in 2017. Investment guru Warren Buffett fell to third, with $84 billion, up from $75.6 billion last year. The list had a record 2,208 billionaires worth a collective $9.1 trillion, an 18 percent increase from last year.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Investors drop deal to buy Weinstein Co.
Investors led by former Obama administration official Maria Contreras-Sweet announced Tuesday they were backing out of a deal to buy The Weinstein Co., after receiving "disappointing information about the viability of completing this transaction." The $500 million deal reportedly unraveled after the investors found out the company's debt was $280 million, not $225 million as previously disclosed. The company was pushed near bankruptcy after dozens of women accused the company co-founder, Harvey Weinstein, of sexual assault and harassment. The investors last week reached an agreement to buy the film studio's assets and re-launch it with a majority-female board, setting up a compensation fund for women who say they were abused by Weinstein.
4. FDA says 23andMe can report on breast cancer risk
The Food and Drug Administration announced Tuesday that it would let genetic testing company 23andMe give customers information about their risk for breast cancer. The company says its "Health + Ancestry" DNA test can detect genetic markers linked to such diseases as celiac disease, Alzheimer's, and Parkinson's, as well as traits like hair loss and lactose intolerance. It also focuses on the BRCA1 and BRCA2 genes to detect mutations that often lead to breast and ovarian cancer. The FDA had prevented the company from providing those results in 2013. The exam is not comprehensive, however, and does not detect the most common mutations in the BRCA1 and BRCA2 gene. The FDA warned that doctors and patients should base decisions about care on more than the 23andMe tests.
5. Oregon man sues Walmart, Dick's Sporting Goods over raising gun-sale age
A 20-year-old Oregon man is suing Walmart and Dick's Sporting Goods for refusing to sell him a .22 caliber rifle because of their policies raising the minimum age for rifle buyers to 21. Both retailers raised the minimum age from 18 after the Parkland, Florida, school shooting, in which police say a 19-year-old shot and killed 17 people with an AR-15 assault-style rifle he purchased legally. Tyler Watson of Gold Hill, Oregon, says in his lawsuits that Walmart and Dick's are violating an Oregon law against age discrimination. "We stand behind our decision and plan to defend it," Walmart spokesman Randy Hargrove said in a statement.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.
-
Critics' choice: Three takes on tavern dining
Feature A second Minetta Tavern, A 1946 dining experience, and a menu with a mission
By The Week US
-
Film reviews: Warfare and A Minecraft Movie
Feature A combat film that puts us in the thick of it and five misfits fall into a cubic-world adventure
By The Week US
-
What to know before lending money to family or friends
the explainer Ensure both your relationship and your finances remain intact
By Becca Stanek, The Week US
-
Inside the Israel-Turkey geopolitical dance across Syria
THE EXPLAINER As Syria struggles in the wake of the Assad regime's collapse, its neighbors are carefully coordinating to avoid potential military confrontations
By Rafi Schwartz, The Week US
-
'Like a sound from hell': Serbia and sonic weapons
The Explainer Half a million people sign petition alleging Serbian police used an illegal 'sound cannon' to disrupt anti-government protests
By Abby Wilson
-
The arrest of the Philippines' former president leaves the country's drug war in disarray
In the Spotlight Rodrigo Duterte was arrested by the ICC earlier this month
By Justin Klawans, The Week US
-
Ukrainian election: who could replace Zelenskyy?
The Explainer Donald Trump's 'dictator' jibe raises pressure on Ukraine to the polls while the country is under martial law
By Sorcha Bradley, The Week UK
-
Why Serbian protesters set off smoke bombs in parliament
THE EXPLAINER Ongoing anti-corruption protests erupted into full view this week as Serbian protesters threw the country's legislature into chaos
By Rafi Schwartz, The Week US
-
Who is the Hat Man? 'Shadow people' and sleep paralysis
In Depth 'Sleep demons' have plagued our dreams throughout the centuries, but the explanation could be medical
By The Week Staff
-
Why Assad fell so fast
The Explainer The newly liberated Syria is in an incredibly precarious position, but it's too soon to succumb to defeatist gloom
By The Week UK
-
Romania's election rerun
The Explainer Shock result of presidential election has been annulled following allegations of Russian interference
By Sorcha Bradley, The Week UK